COEP
Coeptis Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$91.17M
P/E Ratio
—
EPS
$-2.81
Beta
-0.43
52W High
$21.41
52W Low
$6.26
50-Day MA
$11.86
200-Day MA
$13.39
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Coeptis Therapeutics Inc
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and markets brand-name and generic pharmaceuticals and cell therapy platforms for cancer patients. The company is headquartered in Wexford, Pennsylvania.
Fundamentals
| Revenue (TTM) | $1.36M |
| Gross Profit (TTM) | $1.18M |
| EBITDA | $-11.86M |
| Operating Margin | -230.70% |
| Return on Equity | -136.90% |
| Return on Assets | -65.10% |
| Revenue/Share (TTM) | $0.32 |
| Book Value | $2.36 |
| Price-to-Book | 6.69 |
| Price-to-Sales (TTM) | 66.89 |
| EV/Revenue | 62.15 |
| EV/EBITDA | -0.64 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1564.00% |
| Shares Outstanding | $6.22M |
| Float | $5.25M |
| % Insiders | 13.64% |
| % Institutions | 9.00% |
Historical Volatility
HV 10-Day
113.70%
HV 20-Day
91.62%
HV 30-Day
80.85%
HV 60-Day
86.59%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/20/2026